Novartis India Share price

NOVARTIND

Miscellaneous Mid Cap

989.85

0.95 (0.10%)

NSE

BSE

Last updated on 22 Apr, 2026 | 15:31 IST

BUYSELL

Today's High

999.95

Today's Low

976.10

52 Week Low

537.00

52 Week High

1019.95

Free Demat with Zero AMC*

Novartis India Chart

ChartIQ

TradingView

Novartis India Share Key Metrics

Volume

8133.00

Market Cap

2444.02 CR

LTQ@LTP

5@989.85

ATP

987.55 Var Margin

17.05 %

Circuit Range

791.15-1186.65

Delivery %

62.69 %

Value

80.32 L

ASM/GSM

No

Market Lot

1

Summary

Novartis India share price stands at ₹989.85 at 22 Apr, 2026 | 15:31. The stock Novartis India intraday movement has stayed between ₹976.10 and ₹999.95, while on a 52-week basis it has fluctuated from ₹537.00 to ₹1019.95.

In terms of trading activity, Novartis India has recorded a volume of 8133 shares. The Novartis India has a market cap of ₹24690797. The stock’s Average Traded Price (ATP) stands at ₹98755, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 5, 98985.

The Novartis India operates within a circuit range of ₹791.15-1186.65 – ₹791.15-1186.65, with a Value of ₹80.32 L. The Delivery Percentage for the day is 62.69%. Additionally, Novartis India currently falls under the No framework, and trades with a market lot size of 1.

Novartis India Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

42.19

Sector P/B

2.11

Sec. Div. Yield

80.52

Novartis India Resistance and Support

Pivot 993.35

Resistance

First Resistance

1015.5

Second Resistance

1042.1

Third Resistance

1064.25

Support

First Support

966.75

Second Support

944.6

Third Support

918

Novartis India Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

70.68%

Mutual Fund

0%

Insurance

0.51%

Foreign Institutional Investors

0.17%

Domestic Institutional Investors

0.01%

Retail

28.63%

Others

0%

Total Promoters

MAR '26

70.68%

Novartis India Corporate Actions

Date	Agenda
2026-05-12	Audited Results
2026-01-28	Quarterly Results
2025-10-28	Quarterly Results
2025-07-29	Quarterly Results
2025-05-09	Audited Results & Final Dividend
2025-01-28	Quarterly Results
2026-05-12	Audited Results
2026-01-28	Quarterly Results
2025-10-28	Quarterly Results
2025-07-29	Quarterly Results
2025-05-09	Audited Results & Final Dividend
2025-01-28	Quarterly Results

Novartis India News

Novartis India Ltd - 500672 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Novartis India has commenced a postal ballot for shareholders to approve the appointment of Ms. Gowree Gokhale as a Non-Executive and Independent Director for five years. The e-voting period runs from April 17 to May 16, 2026.

Apr 16 2026 17:04:00

Novartis India Ltd - 500672 - Disclosure Under Regulation 31(4) Of The SEBI (Substantial Acquisition Of Shares And Takeover Regulations, 2011)

Novartis AG has agreed to sell its 70.68% equity stake, totaling 1.74 crore shares, in Novartis India Limited. The acquirers are WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners.

Apr 07 2026 22:04:00

Novartis India Ltd - 500672 - Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') And Closure Of Trading Window.

Novartis India's Board is scheduled to meet on May 12, 2026. The meeting's primary agenda is to consider and approve the company's audited financial results for the quarter and full financial year ended March 31, 2026.

Mar 31 2026 13:03:00

Novartis India Ltd - 500672 - Closure of Trading Window

Novartis India's Board is scheduled to meet on May 12, 2026. The meeting's primary agenda is to consider and approve the company's audited financial results for the quarter and full financial year ended March 31, 2026.

Mar 31 2026 13:03:00

Novartis India Ltd - 500672 - Intimation Of The Receipt Of Delhi High Court Order Admitting Company Petition In The Matter Of Novartis India Limited Vs. Commissioner Of Trade And Taxes (W.P.(C) 3892/2026)

Novartis India Limited received a Delhi High Court order admitting its petition challenging a DVAT assessment for AY 2013-14. The assessment involved a demand of ₹10.89 crore tax and a ₹6.85 crore penalty, with the order being procedural.

Mar 30 2026 21:03:00

Novartis India Ltd - 500672 - Intimation Under Reg 30 Of SEBI LODR Of Receipt Of TDS Order As Per Income Tax Act

Novartis India received a demand notice of ₹10.28 crore from the Income-tax department for Assessment Year 2020-21. This demand includes ₹5.76 crore for alleged TDS non-compliance and ₹4.53 crore in interest, with the company planning to appeal the order.

Mar 27 2026 15:03:00

Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Change in Management

Novartis India board approved the appointment of Ms. Gowree Gokhale as an Additional Director (Non-Executive and Independent Director) for a period of five years, effective April 1, 2026. The board also noted the cessation of Ms. Sandra Martyres as an Independent Director from April 18, 2026, upon completion of her second tenure.

Mar 27 2026 11:03:00

Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Cessation

Novartis India's board meeting approved the appointment of Ms. Gowree Gokhale as an Additional Director for a 5-year term starting April 1, 2026. Simultaneously, Ms. Sandra Martyres completed her second and final term as an Independent Director, ceasing to be a Director from April 18, 2026. The board also approved a draft notice for a Postal Ballot to seek members' approval for Ms. Gokhale's appointment.

Mar 27 2026 10:03:00

Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Change in Management

Novartis India's board meeting approved the appointment of Ms. Gowree Gokhale as an Additional Director for a 5-year term starting April 1, 2026. Simultaneously, Ms. Sandra Martyres completed her second and final term as an Independent Director, ceasing to be a Director from April 18, 2026. The board also approved a draft notice for a Postal Ballot to seek members' approval for Ms. Gokhale's appointment.

Mar 27 2026 10:03:00

Novartis India Ltd - 500672 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') Held Today I.E. Friday, March 27, 2026.

Novartis India's board meeting approved the appointment of Ms. Gowree Gokhale as an Additional Director for a 5-year term starting April 1, 2026. Simultaneously, Ms. Sandra Martyres completed her second and final term as an Independent Director, ceasing to be a Director from April 18, 2026. The board also approved a draft notice for a Postal Ballot to seek members' approval for Ms. Gokhale's appointment.

Mar 27 2026 10:03:00

NSE : 9007

BSE : 500672

ISIN : INE234A01025

Novartis India Management

Name	Position
Chandni Maru	Company Secretary & Compliance Officer
Christopher Snook	Chairperson

Novartis India Similar Stocks

Shanti Educational Initiatives Ltd.

182.75

1.75 (0.97%)

Medi Assist Healthcare Services Ltd.

363.15

-6.80 (1.84%)

EFC (I) Ltd.

198.87

-0.21 (0.11%)

Fischer Medical Ventures Ltd.

37.33

-1.67 (4.28%)

SIRCA Paints India Ltd.

445.70

-0.55 (0.12%)

Awfis Space Solutions Ltd.

359.24

9.22 (2.63%)

Mayur Uniquoters Ltd.

585.90

-0.50 (0.09%)

TCPL Packaging Ltd.

2670.20

17.10 (0.64%)

Novartis India FAQs

The Buying Price of Novartis India share is 989.85 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Novartis India stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Novartis India, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Novartis India shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Novartis India shares is 0. Useful to assess the stock's value relative to its book value.

To assess Novartis India’s valuation compare Sector P/E, P/B which are 42.19 & 2.11 with sector averages, along with growth rates and financial metrics.

The Market Cap of Novartis India is 2444.02 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Novartis India share price is 1019.95 & 537.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Novartis India belongs to the Miscellaneous sector.